Veracyte Announces First Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
- Vertiv shares fall on analyst downgrades and options bets
- Most Asian stocks rise as calm returns after CoreWeave shock; Indonesia faces market downgrade
- S&P 500 ends higher as traders shift from AI to healthcare
- Rocket Lab USA (RKLB) Reiterated at Overweight by Cantor Fitzgerald as Neutron Launch Moved to Next Year
- Caterpillar names Derrick York to lead Resource Industries
Veracyte (VCYT) Misses Q1 EPS by 1c
May 5, 2016 5:33 PM EDTVeracyte (NASDAQ: VCYT) reported Q1 EPS of ($0.36), $0.01 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $13.6 million versus the consensus estimate of $13.08 million.
Cash and cash equivalents as of March 31, 2016 totaled $47.5 million, which included net proceeds of $19.2 million from Veracyte's... More



